Abstract 39: APOBEC3A drives acquired resistance to targeted therapies in non small cell lung cancer

Authors: Hideko Isozaki, Ammal Abbasi, Naveed Nikpour, Adam Langenbucher, Wenjia Su, Marcello Stanzione, Lecia V. Sequist, Rémi Buisson, Michael S. Lawrence, Aaron N. Hata

Published: 2021-07-01

DOI: 10.1158/1538-7445.am2021-39

Source: Full article